Charles River Laboratories | CRL - Gross Profit On Sales



Charles River Laboratories reported $291.68M in Gross Profit on Sales for its fiscal quarter ending in June of 2025.


Gross Profit On Sales Change Date
Agilent USD 888M 22M Jul/2025
Align Technology USD 708.12M 28.01M Jun/2025
Bio-Rad Laboratories USD 345.3M 34.7M Jun/2025
Bruker USD 357.9M 33.3M Jun/2025
Cardinal Health USD 2.11B 10M Jun/2025
Charles River Laboratories USD 291.68M 48.42M Jun/2025
Cigna USD 6.16B 445M Jun/2025
CVS Health USD 13.59B 803M Jun/2025
Danaher USD 3.52B 3M Jun/2025
Dentsply International USD 490M 24M Jun/2025
Elevance Health 13.07B 509M Jun/2025
Galapagos EUR 61.25M 98.68M Mar/2025
Hologic USD 576.6M 15.9M Jun/2025
Humana 4.82B 754M Jun/2025
Illumina USD 695M 12M Jun/2025
Incyte USD 1.14B 151.67M Jun/2025
IQVIA Holdings USD 1.05B 251M Jun/2025
Laboratory Of America USD 1.05B 98.2M Jun/2025
Lonza CHF 1.04B 72M Dec/2024
McKesson USD 3.28B 100M Jun/2025
Merck EUR 3.03B 118M Jun/2025
Mettler Toledo International USD 579.88M 54M Jun/2025
Novartis USD 11.51B 1.12B Jun/2025
Pfizer USD 10.88B 248M Jun/2025
Quest Diagnostics USD 904M 35M Jun/2025
Revvity USD 392.56M 17.01M Jun/2025
Thermo Fisher Scientific USD 4.05B 260M Jun/2025
United Therapeutics USD 711M 9.1M Jun/2025
UnitedHealth 98.6B 74.82B Jun/2025
Waters USD 438.02M 53.06M Jun/2025
West Pharmaceutical Services USD 273.9M 42M Jun/2025